Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
17.04B
Market cap17.04B
Price-Earnings ratio
24.74
Price-Earnings ratio24.74
Dividend yield
1.09%
Dividend yield1.09%
Average volume
2.26M
Average volume2.26M
High today
$87.19
High today$87.19
Low today
$86.11
Low today$86.11
Open price
$86.83
Open price$86.83
Volume
139.49K
Volume139.49K
52 Week high
$114.44
52 Week high$114.44
52 Week low
$84.59
52 Week low$84.59

Stock Snapshot

Zimmer Biomet(ZBH) stock is priced at $87.10, giving the company a market capitalization of 17.04B. It carries a P/E multiple of 24.74 and pays a dividend yield of 1.1%.

During the trading session on 2026-03-24, Zimmer Biomet(ZBH) shares reached a daily high of $87.19 and a low of $86.11. At a current price of $87.10, the stock is +1.1% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 139.49K, compared to an average daily volume of 2.26M.

Over the past 52 weeks, Zimmer Biomet(ZBH) stock has traded between a high of $114.44 and a low of $84.59.

Over the past 52 weeks, Zimmer Biomet(ZBH) stock has traded between a high of $114.44 and a low of $84.59.

ZBH News

TipRanks 22h
Zimmer Biomet’s Mymobility Study: Fresh Clinical Data on a Digital Edge in Joint Replacement

Zimmer Biomet Holdings (ZBH) announced an update on their ongoing clinical study. Claim 30% Off TipRanks Premium Unlock hedge fund-level data and powerful inves...

TipRanks 1d
Zimmer Biomet downgraded to Neutral from Buy at BTIG

BTIG analyst Ryan Zimmerman downgraded Zimmer Biomet (ZBH) to Neutral from Buy without a price target The shares are unlikely to generate much return over the q...

Simply Wall St 2d
A Look At Zimmer Biomet Valuation After Revenue Beat EPS Miss And Acquisition Progress

Zimmer Biomet Holdings (ZBH) drew fresh attention after reporting 10.9% year-on-year revenue growth that came in 0.9% above analyst expectations, while slightly...

A Look At Zimmer Biomet Valuation After Revenue Beat EPS Miss And Acquisition Progress

Analyst ratings

60%

of 30 ratings
Buy
26.7%
Hold
60%
Sell
13.3%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.